RecruitingNot ApplicableNCT04296487
Introduction of ACI for Cartilage Repair
Introduction of Autologous Chondrocyte Implantation Procedure for the Treatment of Chondral Defect in the Knee
Sponsor
Centre Hospitalier Universitaire Vaudois
Enrollment
218 participants
Start Date
Sep 1, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
This study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.
Eligibility
Min Age: 15 YearsMax Age: 50 Years
Inclusion Criteria4
- Age between 15 and 50.
- Lesions classified as ICRS Grade III or IV and smaller than 15 cm2
- Lesions that have failed prior therapy (conservative or surgical treatment ≥ six months)
- Subjects who understand and sign the consent form for this study
Exclusion Criteria10
- Body mass index (BMI) of 35 or more
- Osteoarthritis or rheumatoid arthritis
- Diffuse lesion
- Uncorrected mal-alignment, ligamentous instability, or meniscal tear
- Presence of growth cartilage (15-18 years old)
- Active smoking or drug consumption
- Women who are pregnant
- Positive serology for HIV-1 or HIV-2, Hepatitis B and C and syphilis
- Proven allergy to porcine collagen, penicillin and gentamicin
- Poor compliance
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERautologous chondrocytes
autologous chondrocytes implantation (ACI)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04296487
Related Trials
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
NCT069152334 locations
The Biomechanical Outcomes of Autologous Chondrocyte Implantation
NCT069218897 locations
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
NCT0358897512 locations
Knee Registry (Knieregister)
NCT043643341 location
Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions
NCT059424301 location